Walleye Capital LLC Wave Life Sciences Ltd. Transaction History

Walleye Capital LLC

  • $38.9 Billion
  • Q4 2024

A detailed history of Walleye Capital LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Walleye Capital LLC holds 526,698 shares of WVE stock, worth $4.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
526,698
Previous 602,441 12.57%
Holding current value
$4.95 Million
Previous $4.94 Million 31.88%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$8.0 - $16.44 $605,944 - $1.25 Million
-75,743 Reduced 12.57%
526,698 $6.52 Million
Q3 2024

Nov 14, 2024
BUY
$5.12 - $9.01 $3.08 Million - $5.43 Million
602,441 New
602,441 $4.94 Million
Q1 2024

May 15, 2024
SELL
$3.54 - $6.84 $1.34 Million - $2.58 Million
-377,804 Reduced 87.27%
55,129 $340,000
Q4 2023

Feb 14, 2024
BUY
$4.16 - $6.87 $1.18 Million - $1.95 Million
283,973 Added 190.64%
432,933 $2.19 Million
Q3 2023

Nov 14, 2023
BUY
$3.56 - $5.75 $530,297 - $856,520
148,960 New
148,960 $856,000
Q4 2022

Feb 14, 2023
SELL
$3.18 - $7.0 $1 Million - $2.21 Million
-315,474 Reduced 78.57%
86,026 $602,000
Q3 2022

Nov 14, 2022
BUY
$2.37 - $4.28 $951,555 - $1.72 Million
401,500 New
401,500 $1.45 Million
Q1 2022

May 16, 2022
SELL
$2.0 - $3.28 $50,046 - $82,075
-25,023 Closed
0 $0
Q4 2021

Mar 03, 2022
BUY
$3.14 - $5.15 $78,572 - $128,868
25,023 New
25,023 $78,000
Q1 2021

May 17, 2021
SELL
$5.61 - $12.01 $874,071 - $1.87 Million
-155,806 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$6.99 - $9.26 $288,687 - $382,438
-41,300 Reduced 20.95%
155,806 $1.23 Million
Q3 2020

Nov 16, 2020
BUY
$8.49 - $19.54 $1.67 Million - $3.85 Million
197,106 New
197,106 $1.67 Million

Others Institutions Holding WVE

# of Institutions
192
Shares Held
122M
Call Options Held
430K
Put Options Held
330K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $815M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email